Skip to main content

OTCMKTS:EVARF - Lombard Medical Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.01
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Lombard Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVARF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVARF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Lombard Medical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.01.

N/A

The current consensus among 0 investment analysts is to n/a stock in Lombard Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/23/2016BTIG ResearchReiterated RatingHold
i
Rating by Sean Lavin at BTIG Research
8/23/2016BarclaysLower Price TargetEqual Weight$2.50 ➝ $1.00
i
(Data available from 5/16/2016 forward)
Lombard Medical logo
Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.
Read More

Today's Range

Now: $0.01
$0.01
$0.03

50 Day Range

MA: $0.02
$0.01
$0.03

52 Week Range

Now: $0.01
$0.00
$0.08

Volume

50,937 shs

Average Volume

80,859 shs

Market Capitalization

$202,878.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

6.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Lombard Medical?

The following sell-side analysts have issued stock ratings on Lombard Medical in the last twelve months:
View the latest analyst ratings for EVARF.

What is the current price target for Lombard Medical?

0 Wall Street analysts have set twelve-month price targets for Lombard Medical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Lombard Medical in the next year.
View the latest price targets for EVARF.

What is the current consensus analyst rating for Lombard Medical?

Lombard Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EVARF.

What other companies compete with Lombard Medical?

How do I contact Lombard Medical's investor relations team?

Lombard Medical's physical mailing address is 4 TRIDENT PARK BASIL HILL ROAD, DIDCOT X0, OX11 7HJ. The medical equipment provider's listed phone number is 44-0-12-3575-0800. The official website for Lombard Medical is www.lombardmedical.com.